Erratum: Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice (Proceedings of the National Academy of Sciences of the United States of America (2010) 107, (14345-14350) DOI: 10.1073/pnas.1000044107);Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 32, 2010, Pages 14345-14350

  Fujita, Yasuyuki ^a   Abe, Riichiro ^a   Inokuma, Daisuke ^a   Sasaki, Mikako ^a   Hoshina, Daichi ^a   Natsuga, Ken ^a   Nishie, Wataru ^a   McMillan, James R ^a   Nakamura, Hideki ^a   Shimizu, Tadamichi ^b   Akiyama, Masashi ^a   Sawamura, Daisuke ^c   Shimizu, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

Hematopoietic stem cells; Type XVII collagen

Indexed keywords

COLLAGEN; COLLAGEN 17; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; AUTOANTIGEN; COLLAGEN TYPE 17; NONFIBRILLAR COLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CONTROLLED STUDY; EPIDERMOLYSIS BULLOSA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMIDESMOSOME; KERATINOCYTE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SKIN MANIFESTATION; UMBILICAL CORD BLOOD; ANIMAL; BASEMENT MEMBRANE; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; EPIDERMIS; HUMAN; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME;

MUS;

ANIMALS; AUTOANTIGENS; BASEMENT MEMBRANE; BONE MARROW TRANSPLANTATION; EPIDERMIS; EPIDERMOLYSIS BULLOSA; HUMANS; KERATINOCYTES; MEMBRANE PROTEINS; MICE; MICE, SCID; NON-FIBRILLAR COLLAGENS; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77956293326     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1011158107     Document Type: Erratum

References (43)

1. Satake K, Lou J, Lenke LG (2004) Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine (Phila Pa 1976) 29:1971-1979.
2. Herzog EL, Chai L, Krause DS (2003) Plasticity of marrow-derived stem cells. Blood 102:3483-3493.
3. Jiang Y, et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
4. Orlic D, et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705.
5. Kocher AA, et al. (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430-436.
6. Ferrari G, et al. (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530.
7. Yamada M, et al. (2004) Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol 172:1266-1272.
8. Kale S, et al. (2003) Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 112:42-49.
9. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL (2002) Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297:2256-2259.
10. Lagasse E, et al. (2000) Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6:1229-1234.
11. Fine JD, et al. (2008) The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 58:931-950.
12. Mavilio F, et al. (2006) Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12:1397-1402.
13. Banasik MB, McCray PB, Jr (2010) Integrase-defective lentiviral vectors: Progress and applications. Gene Ther 17:150-157.
14. Murata H, et al. (2007) Donor-derived cells and human graft-versus-host disease of the skin. Blood 109:2663-2665.
15. Harris RG, et al. (2004) Lack of a fusion requirement for development of bone marrow-derived epithelia. Science 305:90-93.
16. Inokuma D, et al. (2006) CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes. Stem Cells 24:2810-2816.
17. Nishie W, et al. (2007) Humanization of autoantigen. Nat Med 13:378-383.
18. Fritsch A, et al. (2008) A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest 118:1669-1679.
19. Ito M, et al. (2002) NOD/SCID/gamma(c)(null) mouse: An excellent recipient mouse model for engraftment of human cells. Blood 100:3175-3182.
20. Bauer JW, Lanschuetzer C (2003) Type XVII collagen gene mutations in junctional epidermolysis bullosa and prospects for gene therapy. Clin Exp Dermatol 28:53-60.
21. Robbins PB, Sheu SM, Goodnough JB, Khavari PA (2001) Impact of laminin 5 beta3 gene versus protein replacement on gene expression patterns in junctional epidermolysis bullosa. Hum Gene Ther 12:1443-1448.
22. Robbins PB, et al. (2001) In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa. Proc Natl Acad Sci USA 98:5193-5198.
23. Dellambra E, et al. (2001) Gene correction of integrin beta4-dependent pyloric atresia-junctional epidermolysis bullosa keratinocytes establishes a role for beta4 tyrosines 1422 and 1440 in hemidesmosome assembly. J Biol Chem 276:41336-41342.
24. Seitz CS, Giudice GJ, Balding SD, Marinkovich MP, Khavari PA (1999) BP180 gene delivery in junctional epidermolysis bullosa. Gene Ther 6:42-47.
25. Igoucheva O, Kelly A, Uitto J, Alexeev V (2008) Protein therapeutics for junctional epidermolysis bullosa: Incorporation of recombinant beta3 chain into laminin 332 in beta3-/- keratinocytes in vitro. J Invest Dermatol 128:1476-1486.
26. Woodley DT, et al. (2004) Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa. Nat Med 10:693-695.
27. Wong T, et al. (2008) Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 128:2179-2189.
28. Woodley DT, et al. (2007) Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing. Mol Ther 15:628-635.
29. Hobbs JR, et al. (1981) Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 2:709-712.
30. Sands MS, et al. (1997) Murine mucopolysaccharidosis type VII: Long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation. J Clin Invest 99:1596-1605.
31. Warkentin PI, Dixon MS, Jr, Schafer I, Strandjord SE, Coccia PF (1986) Bone marrow transplantation in Hunter syndrome: A preliminary report. Birth Defects Orig Artic Ser 22:31-39.
32. Krivit W, et al. (1984) Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation. N Engl J Med 311:1606-1611.
33. Gasper PW, et al. (1984) Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation. Nature 312:467-469.
34. Sampaolesi M, et al. (2006) Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444:574-579.
35. Tolar J, et al. (2009) Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 113:1167-1174.
36. Chino T, et al. (2008) Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. Am J Pathol 173:803-814.
37. Wu Y, Chen L, Scott PG, Tredget EE (2007) Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25:2648-2659.
38. Sasaki M, et al. (2008) Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 180:2581-2587.
39. Rieger K, et al. (2005) Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation. Exp Hematol 33:605-611.
40. Dickhut A, et al. (2005) Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cell transplantation originate from host tissue. Ann Hematol 84:722-727.
41. Kopp J, et al. (2005) Hematopoietic stem cell transplantation and subsequent 80% skin exchange by grafts from the same donor in a patient with Herlitz disease. Transplantation 79:255-256.
42. Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image Processing with ImageJ. Biophotonics International 11:36-42.
43. Yanai H (2004) Statcel-The Useful Add-In Software Forms on Excel (OMS, Tokyo) 2nd Ed.